Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Change in Receivables: 2009-2024

Historic Change in Receivables for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to -$10.3 million.

  • Pediatrix Medical's Change in Receivables fell 40159.34% to -$7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.6 million, marking a year-over-year decrease of 60061.28%. This contributed to the annual value of -$10.3 million for FY2024, which is 6083.12% up from last year.
  • According to the latest figures from FY2024, Pediatrix Medical's Change in Receivables is -$10.3 million, which was up 6083.12% from -$26.3 million recorded in FY2023.
  • Pediatrix Medical's Change in Receivables' 5-year high stood at $72.7 million during FY2021, with a 5-year trough of -$37.9 million in FY2020.
  • Over the past 5 years, Pediatrix Medical's median Change in Receivables value was -$10.3 million (recorded in 2024), while the average stood at $753800.0.
  • As far as peak fluctuations go, Pediatrix Medical's Change in Receivables soared by 29171.52% in 2021, and later tumbled by 57403.93% in 2023.
  • Pediatrix Medical's Change in Receivables (Annual) stood at -$37.9 million in 2020, then soared by 291.72% to $72.7 million in 2021, then crashed by 92.38% to $5.5 million in 2022, then crashed by 574.04% to -$26.3 million in 2023, then soared by 60.83% to -$10.3 million in 2024.
  • Its Change in Receivables was -$10.3 million in FY2024, compared to -$26.3 million in FY2023 and $5.5 million in FY2022.